Hosted on MSN21h
Sonnet BioTherapeutics secures EU patent for FHAB technology
Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (F H ...
pharmaphorum1y
Sanofi buys Provention and diabetes drug Tzield for $2.9bn
That includes PRV-3279, a bispecific antibody targeting CD32B and CD79B in phase 2 for systemic lupus erythematosus (SLE), anti-IL15 antibody oredesekimab in phase 2b for coeliac disease ...